Sven Bos

529 total citations
16 papers, 380 citations indexed

About

Sven Bos is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Cancer Research. According to data from OpenAlex, Sven Bos has authored 16 papers receiving a total of 380 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Surgery, 7 papers in Cardiology and Cardiovascular Medicine and 6 papers in Cancer Research. Recurrent topics in Sven Bos's work include Lipoproteins and Cardiovascular Health (11 papers), Cancer, Lipids, and Metabolism (6 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers). Sven Bos is often cited by papers focused on Lipoproteins and Cardiovascular Health (11 papers), Cancer, Lipids, and Metabolism (6 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers). Sven Bos collaborates with scholars based in Netherlands, Austria and Australia. Sven Bos's co-authors include Jeanine E. Roeters van Lennep, Eric J.G. Sijbrands, Adrie J.M. Verhoeven, Monique T. Mulder, Florian Kronenberg, Pim J. de Feyter, Gerald F. Watts, Ranitha Vongpromek, Graham K. Barrell and Martijne H.C. Duvekot and has published in prestigious journals such as Journal of the American College of Cardiology, Atherosclerosis and Journal of Internal Medicine.

In The Last Decade

Sven Bos

16 papers receiving 373 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sven Bos Netherlands	10	279	132	102	79	78	16	380
Konrad Schmidt Austria	6	383 1.4×	151 1.1×	140 1.4×	67 0.8×	135 1.7×	9	492
Rutger Verbeek Netherlands	9	341 1.2×	164 1.2×	83 0.8×	51 0.6×	137 1.8×	16	421
Sophie Gonbert France	6	131 0.5×	101 0.8×	40 0.4×	26 0.3×	112 1.4×	9	266
Fátima Almagro Spain	9	394 1.4×	107 0.8×	154 1.5×	32 0.4×	173 2.2×	11	434
KaWah Li United Kingdom	8	490 1.8×	152 1.2×	173 1.7×	21 0.3×	168 2.2×	9	630
Suzanne Lind Sweden	8	235 0.8×	113 0.9×	49 0.5×	21 0.3×	65 0.8×	10	337
Henning Jansen Germany	11	115 0.4×	110 0.8×	27 0.3×	46 0.6×	83 1.1×	31	427
Rocío Aguado Spain	8	159 0.6×	33 0.3×	64 0.6×	36 0.5×	87 1.1×	19	252
Carmela Morace Italy	13	177 0.6×	51 0.4×	20 0.2×	22 0.3×	49 0.6×	39	417
Anna Maria Ansaldo Italy	8	116 0.4×	161 1.2×	32 0.3×	43 0.5×	13 0.2×	10	304

Countries citing papers authored by Sven Bos

Since Specialization

Citations

This map shows the geographic impact of Sven Bos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sven Bos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sven Bos more than expected).

Fields of papers citing papers by Sven Bos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sven Bos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sven Bos. The network helps show where Sven Bos may publish in the future.

Co-authorship network of co-authors of Sven Bos

This figure shows the co-authorship network connecting the top 25 collaborators of Sven Bos. A scholar is included among the top collaborators of Sven Bos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sven Bos. Sven Bos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Bos, Sven, et al.. (2023). SGLT2 Inhibitor–Related Polycythemia in a Patient With Chronic Heart Failure: A Potential Severe Adverse Event. Circulation Heart Failure. 16(7). e010613–e010613. 7 indexed citations

Rijken, D.C., Sven Bos, Florian Kronenberg, et al.. (2020). How significant is the antifibrinolytic effect of lipoprotein(a) for blood clot lysis?. Thrombosis Research. 198. 210–212. 5 indexed citations

Berk, Kirsten A., Adrie J.M. Verhoeven, Sven Bos, et al.. (2019). Statin treatment increases lipoprotein(a) levels in subjects with low molecular weight apolipoprotein(a) phenotype. Atherosclerosis. 289. 201–205. 39 indexed citations

Verhoeven, Adrie J.M., Kirsten A. Berk, Sven Bos, et al.. (2019). Statin Treatment Increases Lipoprotein(A) Levels In Subjects With Low Molecular Weight Apolipoprotein(A) Phenotype. Atherosclerosis. 287. e111–e112. 4 indexed citations

Sharifi, Mahtab, Sven Bos, Ka Wah Li, et al.. (2017). Greater preclinical atherosclerosis in treated monogenic familial hypercholesterolemia vs. polygenic hypercholesterolemia. Atherosclerosis. 263. 405–411. 56 indexed citations

Vongpromek, Ranitha, Sven Bos, Hideaki Bujo, et al.. (2017). Soluble LR11 associates with aortic root calcification in asymptomatic treated male patients with familial hypercholesterolemia. Atherosclerosis. 265. 299–304. 5 indexed citations

Daele, Paul Van, et al.. (2017). Systemic mastocytosis associates with cardiovascular events despite lower plasma lipid levels. Atherosclerosis. 268. 152–156. 17 indexed citations

Bos, Sven, Michael Phillips, Gerald F. Watts, et al.. (2017). Novel protein biomarkers associated with coronary artery disease in statin-treated patients with familial hypercholesterolemia. Journal of clinical lipidology. 11(3). 682–693. 28 indexed citations

Bos, Sven, Martijne H.C. Duvekot, Adrie J.M. Verhoeven, et al.. (2016). Carotid artery plaques and intima medial thickness in familial hypercholesteraemic patients on long-term statin therapy: A case control study. Atherosclerosis. 256. 62–66. 21 indexed citations

10.

Bos, Sven, Admir Dedic, Lisan A. Neefjes, et al.. (2015). Increased Aortic Valve Calcification in Familial Hypercholesterolemia. Journal of the American College of Cardiology. 66(24). 2687–2695. 37 indexed citations

11.

Brouwers, Corline, Kadir Çalişkan, Sven Bos, et al.. (2015). Health Status and Psychological Distress in Patients with Non-compaction Cardiomyopathy: The Role of Burden Related to Symptoms and Genetic Vulnerability. International Journal of Behavioral Medicine. 22(6). 717–725. 5 indexed citations

12.

Bos, Sven, Martijne H.C. Duvekot, Adrie J.M. Verhoeven, et al.. (2015). Lipoprotein (a) levels are not associated with carotid plaques and carotid intima media thickness in statin-treated patients with familial hypercholesterolemia. Atherosclerosis. 242(1). 226–229. 29 indexed citations

13.

Bos, Sven, et al.. (2014). Latest developments in the treatment of lipoprotein (a). Current Opinion in Lipidology. 25(6). 452–460. 31 indexed citations

14.

Vongpromek, Ranitha, Sven Bos, Adrie J.M. Verhoeven, et al.. (2014). Lipoprotein(a) levels are associated with aortic valve calcification in asymptomatic patients with familial hypercholesterolaemia. Journal of Internal Medicine. 278(2). 166–173. 81 indexed citations

15.

Barrell, Graham K. & Sven Bos. (1989). Changes in serum oestrone sulphate and progesterone levels of red deer hinds during pregnancy. New Zealand Veterinary Journal. 37(1). 1–3. 13 indexed citations

16.

Bos, Sven, et al.. (1953). Essential Hypertension in a 12 Year Old Girl Treated with Hexamethonium Compounds. Acta Paediatrica. 42(6). 570–575. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact